EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Careview Comm Inc (CRVW) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Careview Comm Inc $0.03, price $0.04, upside -18.8%, quality 52 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · US · ISIN US1417431046

CC Careview Comm Inc logo Thin data Sep 23, 2026

Careview Comm Inc

CRVW · US

Overvalued / MonitorQuality is not strong enough to offset the price risk.

!Fair value $0.0298 · Overvalued (−19%)
!Quality 52/100
!Mixed Growth (revenue 5y +6.9 %/yr)
!Loss-making · -33.9% net margin (TTM)
✓Negative equity (buybacks among others) · generates free cash flow
!Trails peers (2/8)
!Narrow moat 13/100
!Evidence only low, so the estimate is less certain
!Weak on valuation: 8 out of 100
Watch Careview Comm Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$0.2805 $0.0073 Fair Value $0.0298 Feb 2020 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range $0.0073 – $0.2805 · fair‑value band $0.0298 – $0.0333 · the $0.0367 price screens above the $0.0298 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.

Follow Careview Comm in your weekly email

Every Wednesday you see whether Careview Comm is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

CareView Communications, Inc. provides video monitoring solutions in the United States.

Show more

CareView Communications, Inc. provides video monitoring solutions in the United States. The company offers CareView Patient Safety System, a video monitoring tool to enhance the practice of nursing, create a better work environment, and make the patient's hospital stay more satisfying, which is used in hospitals, nursing homes, adult living centers, and outpatient care facilities; and CareView Connect, a platform consisting of several products and applications targeted at enhancing the level of care and efficiency; an array of wearable and stationary buttons that allow a resident to summon help either for an emergency or assistance; a mobile app capable of delivering an alert to the caregiver and allows them document information around that alert; and alert management and monitoring system that provides a suite of hardware and software to facilitate a data-driven solution for alert management and monitoring. It also provides Caregiver Platform that offers caregiver connect mobile application to provide an interface to capture critical workflows, such as acknowledging and documenting alert presses by the resident. In addition, the company offers SitterView and TeleMedView that allow hospital staff to use CareView's video cameras to observe and communicate with patients remotely. CareView Communications, Inc. is based in Lewisville, Texas.

Stock analysis

Careview Comm Inc (CRVW) currently trades at $0.0367, while our model-based Fair Value estimate is $0.0298, implying the stock looks roughly 23.2% overvalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of $0.0200 per share, and 2 of the 7 models we run sit above the $0.0367 price.

Bear case: the DCF Models group reads lowest at $0.0200, and 5 of the 7 models stay below the price. Evidence for this calculation is low.

Scenario range: $0.0298 (bear) to $0.0333 (bull), the price of $0.0367 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 52/100 (solid quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Careview Comm Inc reported revenue of $9.0M in FY2025 versus $7.8M in FY2021, a compound +3.7%/yr. Reported net income was −$3.2M in FY2025.

Key figures

Market cap $35.0M · P/S ratio 3.91 · EPS (TTM) $−0.0100 · Net margin −35.5% · Return on assets (EBIT) −23.1% · Operating margin 1.4% · Revenue (TTM) $9.0M · Revenue growth (YoY) −2.1%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 24 out of 100 (low confidence).

What moves the price

The share trades about 49% below its 52-week high and 182% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −45% fair-value upside, at −19%, CRVW screens cheaper than that median.

Fair Value models

Bear $0.0298 Fair Value $0.0298 Bull $0.0333
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF $0.0400 $0.0800 $0.1400 77
Growth DCF $0.0400 $0.0800 $0.1400 75
5Y EBITDA Exit n/a $0.0100 $0.0100 73
All 7 models by family
DCF Models
FCF DCF $0.0400 $0.0800 $0.1400 77
5Y Revenue Exit $0.0100 $0.0200 $0.0300 71
5Y EBITDA Exit n/a $0.0100 $0.0100 73
10Y Revenue Exit $0.0200 $0.0300 $0.0500 65
10Y EBITDA Exit $0.0200 $0.0200 $0.0300 70
Growth DCF
Growth DCF $0.0400 $0.0800 $0.1400 75
Rev-Margin DCF $0.0100 $0.0200 $0.0300 71

Open the full fair value analysis →

Notify me when CRVW reaches fair value

Put CRVW on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 52/100

Of which business quality 54 · Market factors (momentum, volatility) 64

Profitability 50
Margins and returns on capital today
Quality Growth 70
Are margins and returns improving?
Cashflow 62
Earnings quality: real cash, not paper profit
Fin. Strength 33
Balance sheet, leverage, solvency risk
Investment 86
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 70
Price trend over the last 3–12 months (market factor)
52W Momentum 70
Distance to the 52-week high (market factor)
Net Issuance 40
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 50/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+9.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.9%
Start year 2020 (pandemic). Over 10 years: +5.8% a year
Revenue growth 14 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+20.9%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−29.1% (2020) → −0.6% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+34.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +30.9% a year for the price.

CRVW screens 23% overvalued. Compare with Veeva Systems Inc →

Compare Careview Comm Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 134 stocks

Beats the industry median on 2/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 52 · Below median
Fair Value upside −19% · Above median
Profitability
Return on equity (TTM) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets 2% · Above median
Net margin (TTM) −34% · Bottom 25%
Operating margin (TTM) 1% · Below median
Growth and dividend
Revenue growth −2% · Below median
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (TTM) 3.91× · Pricier than median
P/FCF 44.5× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)8 · sector 3
FUTURE (revenue growth)0 · sector 34
PAST (return on equity)0 · sector 5
HEALTH (low debt)0 · sector 98
DIVIDEND (yield)0 · sector 48

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Veeva Systems Inc VEEV $270.75 $297.83 +10%
Pro Medicus Limited PME A$161.31 A$64.50 −60%
BrightSpring Health Services, Inc BTSG $56.55 $26.07 −54%
HealthEquity, Inc HQY $91.75 $100.93 +10%
Hinge Health, Inc HNGE $94.15 $51.66 −45%
10x Genomics, Inc TXG $80.70 $21.71 −73%
Waystar Holding WAY $25.63 $28.19 +10%
XtalPi Holdings 2228 HK$8.39 HK$1.50 −82%
Doximity, Inc DOCS $26.51 $31.41 +18%
Privia Health Group PRVA $19.46 $5.26 −73%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Careview Comm Inc · Fair Value
$0.0298 −23%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Careview Comm Inc Fair Value". https://www.fairvalue-calculator.com/stock/CRVW

Frequently asked questions

Is Careview Comm Inc (CRVW) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of $0.0298 versus a price of $0.0367, about −19% upside (overvalued).
What is the fair value of CRVW?
Our model-based fair value for Careview Comm Inc is $0.0298 (as of Sep 23, 2026), built from audited fundamentals. The current price: $0.0367.
What is the quality score of CRVW?
Careview Comm Inc has a Quality Score of 52/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Careview Comm Inc (CRVW)?
Our model-based price target is the fair value of $0.0298 (as of Sep 23, 2026) from 7 valuation models. Cautious scenario $0.0298, optimistic scenario $0.0333. It is a calculation from audited fundamentals, not an analyst target.
What is the Careview Comm Inc stock forecast for 2026?
Our models put fair value at $0.0298, about −19% upside versus a price of $0.0367 (overvalued). Cautious scenario $0.0298, optimistic scenario $0.0333. The calculation is refreshed regularly with new filings.
What is the revenue of Careview Comm Inc (CRVW)?
Careview Comm Inc reported trailing-twelve-month revenue of about $9.0M (latest available figure, as of Sep 23, 2026).
What growth is priced into Careview Comm Inc (CRVW)?
For today's price to be fair in a discounted-cash-flow model, Careview Comm Inc would have to grow free cash flow by +34.0 % per year for five years (discount rate 9.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +6.9 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of CRVW use?
Our models discount Careview Comm Inc at 9.7 %: a base by market capitalisation (nano), country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Careview Comm Inc that is +34.0 % per year a year over ten years, using the same discount rate (9.7 %) and the same formula as our fair value.
How much growth has Careview Comm Inc (CRVW) delivered so far?
Over the past 5 years revenue at Careview Comm Inc grew +6.9 % a year. The price currently implies +34.0 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Careview Comm Inc (CRVW) growing?
The median revenue growth in the sector is +4.2 % a year. That is the yardstick for the growth priced into Careview Comm Inc (+34.0 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Careview Comm Inc (CRVW)?
The free-cash-flow yield on the price is 3.68 %: that much free cash flow Careview Comm Inc produces per unit of market value. When it exceeds the discount rate of our models (9.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Careview Comm Inc (CRVW)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Careview Comm Inc it is $0.0298 per share (as of Sep 23, 2026), against a price of $0.0367. It is the blended result of 7 valuation models (cash flow, earnings, asset, dividend).
Is Careview Comm Inc stock overvalued or undervalued in 2026?
As of Sep 23, 2026, CRVW trades above its calculated fair value: price $0.0367, fair value $0.0298, a gap of about −19% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CRVW?
No. The price is what the market pays today ($0.0367); the fair value is what the company's own numbers justify ($0.0298). For Careview Comm Inc the two are $0.0069 per share apart. That gap is exactly why we show both numbers side by side.
How much is Careview Comm Inc worth?
The market values Careview Comm Inc at about $35.0M (market capitalisation, as of Sep 23, 2026). Per share that is $0.0367; our models calculate a fair value of $0.0298 per share.
What do the bullish and bearish scenarios say about CRVW?
Our models span a range for Careview Comm Inc: cautious scenario $0.0298, base $0.0298, optimistic $0.0333 per share (as of Sep 23, 2026, price $0.0367). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Careview Comm Inc (CRVW)?
Balance-sheet figures for Careview Comm Inc (as of Sep 23, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 52/100, which measures business quality independently of the share price.
How far is CRVW from its 52-week high?
Careview Comm Inc trades at $0.0367, about 49% below its 52-week high of $0.0725 and 182% above the low of $0.0130 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0298 is for.
Which stocks are comparable to Careview Comm Inc?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, HealthEquity, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Careview Comm Inc stock attractive at the current price?
The data as of Sep 23, 2026: price $0.0367, calculated fair value $0.0298 (−19%), Quality Score 52/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CRVW calculated?
We run Careview Comm Inc through 7 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0298, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Careview Comm Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Careview Comm Inc (CRVW)?
The closing price on Sep 23, 2026 was $0.0367. Our model-based fair value is $0.0298, about −19% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Careview Comm Inc right now?
The price sits above even our optimistic bull case ($0.0333). The favourable scenario is already priced in. Solid but not exceptional quality (52/100) and above fair value, neither a clear bargain nor a standout compounder. The models converge in a tight band ($0.0298 to $0.0333), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Careview Comm Inc

How large is the market capitalisation of Careview Comm Inc (CRVW)?
The market capitalisation of Careview Comm Inc is $35.0M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Careview Comm Inc (CRVW)?
The price-to-sales ratio of Careview Comm Inc is 3.91 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Careview Comm Inc (CRVW)?
Earnings per share at Careview Comm Inc are $−0.0100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Careview Comm Inc (CRVW)?
The net margin of Careview Comm Inc is −35.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Careview Comm Inc (CRVW)?
On an EBIT basis the return on assets of Careview Comm Inc is −23.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Careview Comm Inc (CRVW)?
The operating margin of Careview Comm Inc is 1.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Careview Comm Inc (CRVW)?
Revenue at Careview Comm Inc is growing −2.1% versus a year earlier (3y avg +4.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net debt does Careview Comm Inc (CRVW) carry?
The net debt of Careview Comm Inc is $19.2M (fiscal year 2025, ≈ 24.3 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Careview Comm Inc in the live analysis

One click puts Careview Comm Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.